ASP Isotopes (NASDAQ:ASPI) Stock Price Down 4.5% - Should You Sell?

Key Points

• ASP Isotopes Inc. (NASDAQ:ASPI) shares fell by 4.5%, trading as low as $8.75 and closing at $8.84, with a significant drop in trading volume.
• Analysts from Canaccord Genuity have raised their price target for ASP Isotopes from $8.50 to $11.00 and maintained a "buy" rating, while the consensus target price is now $7.75.
• The company reported quarterly earnings of ($1.03) EPS, missing expectations significantly, indicating strong financial challenges highlighted by a negative net margin of 2,181.62%.

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report)'s stock price was down 4.5% during trading on Tuesday . The stock traded as low as $8.75 and last traded at $8.84. Approximately 780,178 shares changed hands during mid-day trading, a decline of 76% from the average daily volume of 3,198,586 shares. The stock had previously closed at $9.26.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group reissued a "buy" rating and issued a $11.00 price target on shares of ASP Isotopes in a report on Wednesday. Two research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock has a consensus rating of "Buy" and a consensus price target of $7.75.

ASP Isotopes Trading Up 8.0%

The firm's fifty day moving average price is $9.35 and its 200-day moving average price is $7.31. The company has a market cap of $906.23 million, a price-to-earnings ratio of -16.16 and a beta of 3.35. The company has a debt-to-equity ratio of 3.53, a current ratio of 14.72 and a quick ratio of 14.56.

ASP Isotopes (NASDAQ:ASPI - Get Free Report) last issued its quarterly earnings data on Thursday, August 14th. The company reported ($1.03) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.92). ASP Isotopes had a negative net margin of 2,181.62% and a negative return on equity of 239.22%. The firm had revenue of $1.20 million during the quarter, compared to the consensus estimate of $1.60 million. On average, equities analysts expect that ASP Isotopes Inc. will post -0.24 EPS for the current fiscal year.

Insider Transactions at ASP Isotopes

In related news, Director Duncan Moore sold 75,000 shares of ASP Isotopes stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $9.28, for a total transaction of $696,000.00. Following the sale, the director directly owned 994,553 shares in the company, valued at $9,229,451.84. The trade was a 7.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Robert Ainscow sold 8,438 shares of the firm's stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $8.53, for a total value of $71,976.14. Following the transaction, the chief operating officer directly owned 1,411,554 shares of the company's stock, valued at $12,040,555.62. This represents a 0.59% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 245,591 shares of company stock worth $2,139,790. Company insiders own 21.40% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of ASPI. Northern Trust Corp boosted its stake in shares of ASP Isotopes by 15.5% during the 4th quarter. Northern Trust Corp now owns 435,688 shares of the company's stock worth $1,974,000 after acquiring an additional 58,525 shares in the last quarter. BNP Paribas Financial Markets purchased a new stake in shares of ASP Isotopes during the fourth quarter valued at $34,000. Bank of America Corp DE boosted its position in shares of ASP Isotopes by 318.7% in the 4th quarter. Bank of America Corp DE now owns 113,084 shares of the company's stock valued at $512,000 after purchasing an additional 86,075 shares during the period. Deutsche Bank AG raised its holdings in ASP Isotopes by 25.2% during the 4th quarter. Deutsche Bank AG now owns 33,587 shares of the company's stock worth $152,000 after buying an additional 6,763 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in ASP Isotopes by 33.5% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 28,904 shares of the company's stock valued at $131,000 after buying an additional 7,250 shares in the last quarter. Institutional investors own 16.80% of the company's stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.